State Street Corp Alx Oncology Holdings Inc Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

A detailed history of State Street Corp transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, State Street Corp holds 705,547 shares of ALXO stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
705,547
Previous 553,867 27.39%
Holding current value
$1.39 Million
Previous $6.18 Million 31.11%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$5.84 - $17.56 $885,811 - $2.66 Million
151,680 Added 27.39%
705,547 $4.25 Million
Q1 2024

May 15, 2024
BUY
$10.95 - $16.79 $573,462 - $879,309
52,371 Added 10.44%
553,867 $6.18 Million
Q4 2023

Feb 14, 2024
BUY
$4.81 - $15.38 $539,378 - $1.72 Million
112,137 Added 28.8%
501,496 $7.47 Million
Q3 2023

Nov 14, 2023
BUY
$4.19 - $7.35 $33,268 - $58,359
7,940 Added 2.08%
389,359 $1.87 Million
Q2 2023

Aug 14, 2023
SELL
$4.37 - $9.56 $54,734 - $119,739
-12,525 Reduced 3.18%
381,419 $2.86 Million
Q1 2023

May 15, 2023
BUY
$4.52 - $11.71 $1,780 - $4,613
394 Added 0.1%
393,944 $1.78 Million
Q4 2022

Feb 14, 2023
BUY
$9.51 - $12.95 $85,466 - $116,381
8,987 Added 2.34%
393,550 $4.44 Million
Q3 2022

Nov 15, 2022
BUY
$8.23 - $15.14 $236,678 - $435,396
28,758 Added 8.08%
384,563 $3.68 Million
Q2 2022

Aug 15, 2022
SELL
$5.89 - $19.46 $10.5 Million - $34.6 Million
-1,777,939 Reduced 83.32%
355,805 $2.88 Million
Q1 2022

May 16, 2022
BUY
$13.65 - $22.06 $9.44 Million - $15.3 Million
691,410 Added 47.94%
2,133,744 $36.1 Million
Q4 2021

Feb 14, 2022
BUY
$21.49 - $74.4 $12.5 Million - $43.2 Million
580,779 Added 67.41%
1,442,334 $31 Million
Q3 2021

Nov 15, 2021
SELL
$52.51 - $80.91 $10.2 Million - $15.6 Million
-193,322 Reduced 18.33%
861,555 $63.6 Million
Q2 2021

Aug 16, 2021
BUY
$52.2 - $75.23 $6.65 Million - $9.59 Million
127,438 Added 13.74%
1,054,877 $57.7 Million
Q1 2021

May 17, 2021
BUY
$62.84 - $87.68 $34.2 Million - $47.8 Million
544,900 Added 142.44%
927,439 $68.4 Million
Q4 2020

Feb 16, 2021
BUY
$34.11 - $112.26 $9.18 Million - $30.2 Million
269,016 Added 236.97%
382,539 $33 Million
Q3 2020

Nov 10, 2020
BUY
$29.36 - $47.1 $3.33 Million - $5.35 Million
113,523 New
113,523 $4.28 Million

Others Institutions Holding ALXO

# of Institutions
122
Shares Held
40.7M
Call Options Held
518K
Put Options Held
142K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $80.3M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email